Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 4
4 · NATURES SUNSHINE PRODUCTS INC · Filed Jan 24, 2022
Insider Transaction Report
Form 4
Transactions
- Other
Common Stock
2022-01-07+9,558→ 49,394 total(indirect: by Fosun Industrial Co., Limited) - Other
Common Stock
2022-01-21$8.72/sh+25,000$218,000→ 74,394 total(indirect: by Fosun Industrial Co., Limited) - Other
Common Stock
2021-04-12+711→ 39,836 total(indirect: by Fosun Industrial Co., Limited)
Holdings
- 2,854,607
Common Stock
Footnotes (5)
- [F1]These shares represent incremental shares granted by the Issuer as an adjustment to the vested option award of a former director of the Issuer (the "Former Director"). These shares initially reported on a Form 4 filed by the Former Director, but were actually issued to Fosun Industrial Co., Limited. Due to this oversight, a Form 4 was not previously filed by the Reporting Person regarding this issuance.
- [F2]Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person.
- [F3]These shares represent shares that were issued to Fosun Industrial Co., Limited on the instruction of the Former Director upon the delivery of certain vested restricted stock units that were initially granted to the Former Director, as agreed between the Former Director and the Reporting Person.
- [F4]These shares represent shares that were issued to Fosun Industrial Co., Limited on the instruction of the Former Director upon the exercise of certain stock options (the "Options") that were initially granted to the Former Director, as agreed between the Former Director and the Reporting Person.
- [F5]Represents the exercise price paid by Fosun Industrial Co., Limited for the shares underlying the Options upon the exercise of the Options.